Evidence map›Paper›PMID 29885952›Full record

ArticleJACC. Heart failure2018

Comparing Measures to Assess Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction.

Rebecca Napier, Steven E McNulty, David T Eton, Margaret M Redfield, Omar AbouEzzeddine, Shannon M Dunlay

Registry-linked trialOpen access · greenAbstract readComparative StudyMulticenter Study
In one paragraph

Article in JACC. Heart failure, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04327596 (Randomized Clinical Trial of Radiofrequency Ablation for Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction for Reduced Healthcare Utilization), which is not on this map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04327596 naterminatednot on this mapstarted 2021, after this paper: background citation

Randomized Clinical Trial of Radiofrequency Ablation for Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction for Reduced Healthcare Utilization

TypeinterventionalSponsorUniversity of RochesterRan2021 to 2021Enrolled2ConditionsHeart Failure With Preserved Ejection FractionArmsRF ablation of AF using CARTO 3 and a Thermocool ST SF ablation catheter
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The Role of Renal Denervation in HFpEF.Journal of clinical medicine · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. Global epidemiology of heart failure.Nature reviews. Cardiology · 2024
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Rebecca NapierDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Steven E McNultyDuke Clinical Research Institute, Durham, North Carolina.
David T EtonDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Margaret M RedfieldDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Omar AbouEzzeddineDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Shannon M DunlayDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. Electronic address: dunlay.shannon@mayo.edu.
Mayo Clinic · USClinical Research Institute · USMayo Clinic in Florida · US

Funding

Heart Failure Clinical Research Network Coordinating CenterU10HL084904 · NHLBI · DUKE UNIVERSITY · PI ANSTROM, KEVIN J, HERNANDEZ, ADRIAN · 2012 to 2018
$38.0M
Mayo Heart Failure Regional Clinical CenterU10HL110262 · NHLBI · MAYO CLINIC ROCHESTER · PI REDFIELD, MARGARET M · 2012 to 2018
$3.6M
Heart Failure Clinical Research Network Regional Clinical Center (U10)U10HL110312 · NHLBI · DUKE UNIVERSITY · PI FELKER, GARY M · 2012 to 2018
$3.5M
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)U10HL110309 · NHLBI · WASHINGTON UNIVERSITY · PI DAVILA-ROMAN, VICTOR G., MANN, DOUGLAS L · 2012 to 2018
$3.5M
Harvard Regional Clinical Center of the NHLBI Heart Failure NetworkU10HL110337 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI GIVERTZ, MICHAEL M, LEWIS, GREGORY DYER · 2012 to 2018
$3.5M
Renal Sympathetic Denervation in Congestive Heart FailureU10HL110336 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI STARLING, RANDALL CARSON, TANG, WAI HONG WILSON · 2012 to 2018
$2.5M
Heart Failure Clinical Trials NetworkU10HL110302 · NHLBI · EMORY UNIVERSITY · PI SMITH, ANDREW · 2012 to 2018
$2.5M
Mid Atlantic Heart Failure NetworkU10HL110338 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI CAPPOLA, THOMAS P., MARGULIES, KENNETH BER · 2012 to 2018
$2.4M
New England, New York and Quebec Regional Clinical CenterU10HL110342 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HUGGINS, GORDON S, VANBUREN, PETER C · 2012 to 2018
$2.3M
The Jefferson Regional Clinical Center for Heart Failure NetworkU10HL110297 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI WHELLAN, DAVID J · 2012 to 2018
$2.0M
The Minnesota Heart Failure Consortium: A Regional Clinical CenterU01HL084861 · NHLBI · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI GOLDSMITH, STEVEN ROBERT · 2006 to 2011
$1.5M
End of Life Preferences and Healthcare Resource Use in Heart Failure PatientsK23HL116643 · NHLBI · MAYO CLINIC ROCHESTER · PI DUNLAY, SHANNON MARIE · 2013 to 2017
$739k
NHLBI NIH HHS K23 HL116643NHLBI NIH HHS U01 HL084861NHLBI NIH HHS U10 HL084904NHLBI NIH HHS U10 HL110262NHLBI NIH HHS U10 HL110297NHLBI NIH HHS U10 HL110302NHLBI NIH HHS U10 HL110309NHLBI NIH HHS U10 HL110312NHLBI NIH HHS U10 HL110336NHLBI NIH HHS U10 HL110337NHLBI NIH HHS U10 HL110338NHLBI NIH HHS U10 HL110342
6 · The paper itself

Abstract

objectivesThis study sought to compare the performance of 2 health-related quality of life (HRQOL) questionnaires in patients with heart failure with preserved ejection fraction (HFpEF).

backgroundThe ability to accurately assess HRQOL over time is important in the care of patients with heart failure. The validity and reliability of HRQOL tools including the Minnesota Living with Heart Failure Questionnaire (MLHFQ) and the Kansas City Cardiomyopathy Questionnaire (KCCQ) has not been fully determined or compared in patients with HFpEF.

methodsAmong patients with stable chronic HFpEF enrolled in the NEAT (Nitrate Effect on Activity Tolerance in Heart Failure) trial (n = 110), the study evaluated and compared reliability, validity, and responsiveness to change of the MLHFQ and KCCQ at baseline, 6 weeks, and 12 weeks.

resultsInternal consistency was good and comparable for MLHFQ and KCCQ domains measuring similar aspects of HRQOL at baseline including the MLHFQ physical (Cronbach's α = 0.93) compared with the KCCQ clinical summary (α = 0.91), and the MLHFQ emotional (α = 0.92) compared with the KCCQ quality of life (α = 0.87). Correlations with New York Heart Association functional class (Spearman rho; r

conclusionsThese data suggest that both the MLHFQ and KCCQ are reliable and valid tools to assess HRQOL in HFpEF. The KCCQ was more strongly correlated with baseline functional status parameters, while the MLHFQ was more responsive to improvement in 6MWT.

Indexed as

Quality of LifeAgedCross-Over StudiesDouble-Blind MethodFemaleHealth StatusHealth Status IndicatorsHeart FailureHumansMaleMiddle AgedReproducibility of ResultsStroke VolumeSurveys and Questionnairesheart failurequality of life

Identifiers

PMID29885952
PMCPMC6026057
OpenAlexW2807273711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.